Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Management of fingolimod-associated macular edema.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
RECENT ADVANCES IN MESENCHYMAL STEM CELL IMMUNOMODULATION. THE ROLE OF MICROVESICLES.
Off-pump coronary surgery in a patient with multiple sclerosis.
OLFACTORY ENSHEATHING GLIA CELL THERAPY AND TUBULAR CONDUIT ENHANCE NERVE REGENERATION AFTER MOUSE SCIATIC NERVE TRANSECTION.
Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
The psychosocial difficulties in brain disorders that explain short term changes in health outcomes.
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).
Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Fingolimod and multiple sclerosis: Four cautionary tales.
Paracrine Effects of Mesenchymal Stem Cells-Conditioned Medium on Microglial Cytokines Expression and Nitric Oxide Production.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
[Optic neuropathy after retrobulbar neuritis in multiple sclerosis : Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?].
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!
Pages
« first
‹ previous
…
369
370
371
372
373
374
375
376
377
…
next ›
last »